Lab
Laboratorio Clinico Los Colobos, INC
Laboratorio Clinico Los Colobos, INC was paid $777K by Medicaid between Oct 2019 and Dec 2024, across 33 billing codes. Its largest line is G2023, Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source — 21% of everything it billed.
33Billing provider infoLABORATORIO CLINICO LOS COLOBOS, INC
CAROLINA, PR 00985
CAROLINA, PR 00985
33aNPI1114933900assigned 07/31/2006
33bProvider typeClinical Medical Laboratory
28Total paid$777K
24GClaims47,174
24DCodes billed33
24AFirst – last monthOct 2019 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#167 of 777
Median peer was paid$278K
This provider vs. median2.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 81 | $520.66 | |
| 2020 | 3,728 | $39K | |
| 2021 | 12,620 | $279K | |
| 2022 | 12,285 | $228K | |
| 2023 | 10,059 | $125K | |
| 2024incomplete | 8,401 | $104K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 21% | 6,705 | 5,976 | $162K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 20% | 4,588 | 4,113 | $159K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 18% | 2,832 | 2,635 | $142K |
| 84443 | Thyroid stimulating hormone (TSH) | 5.7% | 3,213 | 2,963 | $44K |
| 80061 | Lipid panel | 5.0% | 3,153 | 2,902 | $39K |
| 80053 | Comprehensive metabolic panel | 4.3% | 3,767 | 3,453 | $33K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.8% | 4,613 | 4,092 | $30K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.5% | 2,163 | 1,610 | $27K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.9% | 815 | 754 | $22K |
| 86738 | 2.6% | 1,670 | 1,489 | $20K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.9% | 1,616 | 1,485 | $15K |
| 81000 | 1.7% | 4,355 | 3,945 | $13K |
21 more codes
| 86328 | 1.6% | 651 | $12K | |
| 85027 | 1.4% | 1,933 | $11K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.3% | 459 | $10K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,302 | $7K |
| 84439 | <1% | 576 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 725 | $5K |
| 82274 | <1% | 176 | $3K | |
| 80050 | General health panel | <1% | 288 | $3K |
| 84436 | <1% | 368 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 54 | $2K |
| 82043 | <1% | 350 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 43 | $2K |
| 87400 | <1% | 162 | $2K | |
| 86592 | <1% | 307 | $1K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 71 | $570.89 |
| 84479 | <1% | 82 | $512.06 | |
| 82570 | <1% | 82 | $411.70 | |
| 87088 | <1% | 13 | $85.34 | |
| 85730 | <1% | 14 | $66.93 | |
| 85610 | <1% | 15 | $46.59 | |
| 82947 | <1% | 13 | $42.41 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMENDEZ, HERMINIO (OWNER)